Immuron Limited reported unaudited Sales results for First Half 2024. For the period, Australia Sales of Travelan increased to AUD 1,853,048 in first half, Fiscal 2024, compared to AUD 260,205 in first half, Fiscal year 2023. Sales increased by $1,054,164 (132%) on the pre-pandemic peak period (first half, FY20).

This increase partially reflects 3 months (May, June, July) of backorders accrued while awaiting GMP Clearance from the TGA. USA Sales of Travelan increased to AUD 481,920 in first half, Fiscal year 2024, compared to AUD 295,411 in first half, Fiscal year 2023. Sales were lower by $31,633 (-6%) on the pre-pandemic peak period (first half, Fiscal year 2023).

International Trade Administration Total U.S. citizen international visitor departures from the United States in September 2023 were 17% higher than in September 2022. Immuron?s target departure markets, July - September 2023 departures were 1% higher than the pre-pandemic period July - September 2019.